Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trajan Group Holdings's Other Operating Expense for the
six
months ended in Dec. 2025 was A$2.8 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$10.8 Mil.
Trajan Group Holdings's quarterly Other Operating Expense
increased
from Dec. 2024 (A$3.3 Mil) to Jun. 2025 (A$7.9 Mil) but then
declined
from Jun. 2025 (A$7.9 Mil) to Dec. 2025 (A$2.8 Mil).
Trajan Group Holdings's annual Other Operating Expense
increased
from Jun. 2023 (A$10.0 Mil) to Jun. 2024 (A$12.4 Mil) but then
declined
from Jun. 2024 (A$12.4 Mil) to Jun. 2025 (A$11.2 Mil).
Trajan Group Holdings Other Operating Expense Related Terms
Trajan Group Holdings Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Trajan Group Holdings's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trajan Group Holdings Other Operating Expense Chart
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$10.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of A$10.8 Mil mean?
Trajan Group Holdings (ASX:TRJ) has a Other Operating Expense of A$10.8 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Trajan Group Holdings and its competitors.
Is Trajan Group Holdings' Other Operating Expense too high?
Trajan Group Holdings' current Other Operating Expense is A$10.8 Mil. Overall, Trajan Group Holdings has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trajan Group Holdings' Other Operating Expense compare to ISRG and BDX?
Trajan Group Holdings' Other Operating Expense of A$10.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Trajan Group Holdings and its competitors. Trajan Group Holdings's current Other Operating Expense is A$10.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trajan Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Trajan Group Holdings (ASX:TRJ) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.12, compared to a current price of A$0.21 — trading 81.7% below its estimated fair value. The current Other Operating Expense is A$10.8 Mil. Trajan Group Holdings' overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Trajan Group Holdings (ASX:TRJ), the current Other Operating Expense is A$10.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trajan Group Holdings (ASX:TRJ) Overvalued in 2026?
Based on GuruFocus' analysis, Trajan Group Holdings stock appears to be undervalued.
The current stock price of A$0.21 is trading 81.7% below its estimated GF Value™ of A$1.12.
GuruFocus considers Trajan Group Holdings to be Possible Value Trap.
Key valuation signals for ASX:TRJ:
Other Operating Expense: A$10.8 Mil
GF Value™: A$1.12 vs. price of A$0.21 (81.7% below fair value)
No single metric tells the full story. See the ASX:TRJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and consumables, which include parts, supplies, components, and consumable products worldwide. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
35GF Score
Get the complete analysis for ASX:TRJ
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:TRJ has been successfully added to your 
